CLEW Receives FDA Emergency Use Authorization (EUA) for its Predictive Analytics Platform in Support of COVID-19 Patients
CLEWICU is the only device authorized by the FDA to provide early identification of patients who are likely to experience respiratory failure or hemodynamic instability, both potentially common but significant complications associated with COVID-19
Relyens forges five exclusive technology partnerships to enhance the operational safety of healthcare professionals and local authorities
Prominent healthcare technology pioneer to advise CLEW as the company expands its product offering across the entire continuum of care
Featuring healthcare industry experts, the program will show how critical care units are using AI-Machine Learning to deliver true patient value
CLEW used Google Compute Engine to build a reliable, scalable, cloud-based machine learning platform to develop and train its critical care algorithms.